Tom 1, Nr 4 (2016)
Wytyczne / stanowisko ekspertów
Opublikowany online: 2017-02-21
Wyświetlenia strony
1124
Wyświetlenia/pobrania artykułu
7373
Standardy postępowania w przypadkach choroby nowotworowej u kobiety w ciąży Część I. Wiadomości ogólne: epidemiologia, diagnostyka, leczenie, poradnictwo genetyczne
Ginekologia i Perinatologia Praktyczna 2016;1(4):172-188.
Streszczenie
Brak
Słowa kluczowe: choroba nowotworowarak szyjki macicy
Referencje
- Fader AN, Alward EK, Niederhauser A, et al. Cervical dysplasia in pregnancy: a multi-institutional evaluation. Am J Obstet Gynecol. 2010; 203(2): 113.e1–113.e6.
- Hannigan E. Cervical Cancer in Pregnancy. Clinical Obstetrics and Gynecology. 1990; 33(4): 837–845.
- Dudan R, Yon J, Ford J, et al. Carcinoma of the cervix and pregnancy. Gynecologic Oncology. 1973; 1(4): 283–289.
- YOST N, SANTOSO J, MCINTIRE D, et al. Postpartum Regression Rates of Antepartum Cervical Intraepithelial Neoplasia II and III Lesions. Obset Gynecol. 1999; 93(3): 359–362.
- ACOG Practice Bulletin No. 99: Management of Abnormal Cervical Cytology and Histology. Obstet Gynecol. 2008; 112(6): 1419–1444.
- Rozporządzenie Ministra Zdrowia z dnia 20 września 2012r. W sprawie standardów postępowania medycznego przy udzielaniu świadczeń zdrowotnych z zakresu opieki okołoporodowej sprawowanej nad kobietą w okresie fizjologicznej ciąży, fizjologicznego porodu, połogu oraz opieki nad noworodkiem Dz N poz 1100.
- Orr JW, Barrett JM, Orr PF, et al. The efficacy and safety of the cytobrush during pregnancy. Gynecol Oncol. 1992; 44(3): 260–262.
- Stillson T, Knight AL, Elswick RK. The effectiveness and safety of two cervical cytologic techniques during pregnancy. J Fam Pract. 1997; 45(2): 159–163.
- Wright TC Jr, Massad S, Dunton CJ i wsp. 2006 Consensus guidelines for the managament of women with abnormal cervical concer screening test. Am. J. Obstet Gynecol 2007, 197, 346-55.
- Dunn TS, Bajaj JE, Stamm CA, et al. Management of the minimally abnormal papanicolaou smear in pregnancy. J Low Genit Tract Dis. 2001; 5(3): 133–137.
- Kohan S, Beckman EM, Bigelow B, et al. The role of colposcopy in the management of cervical intraepithelial neoplasia during pregnancy and postpartum. J Reprod Med. 1980; 25(5): 279–284.
- Nasierowska- Guttmejer A, Kędzie W, Wojtylak S, et al. Polish recommendations regarding diagnostics and treatment of cervical squamous intraepithelial lesions according to the CAP/ASCCP guidelines. Gin Pol. 2016; 87(9): 670–676.
- Fader AN, Alward EK, Niederhauser A, et al. Cervical dysplasia in pregnancy: a multi-institutional evaluation. Am J Obstet Gynecol. 2010; 203(2): 113.e1–113.e6.
- Van Calsteren K, Vergote I, Amant F. Cervical neoplasia during pregnancy: diagnosis, management and prognosis. Best Pract Res Clin Obstet Gynaecol. 2005; 19(4): 611–630.
- Economos K, Perez Veridiano N, Delke I, et al. Abnormal cervical cytology in pregnancy: a 17-year experience. Obstet Gynecol. 1993; 81(6): 915–918.
- Muller CY, Smith HO. Cervical neoplasia complicating pregnancy. Obstet Gynecol Clin North Am. 2005; 32(4): 533–546.
- Mukhopadhyay A, Shinde A, Naik R. Ovarian cysts and cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016; 33: 58–72.
- Sherard GB, Hodson CA, Williams HJ, et al. Adnexal masses and pregnancy: a 12-year experience. Am J Obstet Gynecol. 2003; 189(2): 358–62; discussion 362.
- Balci O, Gezginc K, Karatayli R, et al. Management and outcomes of adnexal masses during pregnancy: a 6-year experience. J Obstet Gynaecol Res. 2008; 34(4): 524–528.
- Giuntoli RL, Vang RS, Bristow RE. Evaluation and management of adnexal masses during pregnancy. Clin Obstet Gynecol. 2006; 49(3): 492–505.
- Oehler MK, Wain GV, Brand A. Gynaecological malignancies in pregnancy: a review. Aust N Z J Obstet Gynaecol. 2003; 43(6): 414–420.
- Cavaco-Gomes J, Jorge Moreira C, Rocha A, et al. Investigation and Management of Adnexal Masses in Pregnancy. Scientifica (Cairo). 2016; 2016: 3012802.
- Zhao XY, Huang HF, Lian LJ, et al. Ovarian cancer in pregnancy: a clinicopathologic analysis of 22 cases and review of the literature. Int J Gynecol Cancer. 2006; 16(1): 8–15.
- Blake EA, Kodama M, Yunokawa M, et al. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2015; 186: 97–105.
- Blake EA, Carter CM, Kashani BN, et al. Feto-maternal outcomes of pregnancy complicated by ovarian sex-cord stromal tumor: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2014; 175: 1–7.
- Kodama M, Grubbs BH, Blake EA, et al. Feto-maternal outcomes of pregnancy complicated by ovarian malignant germ cell tumor: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2014; 181: 145–156.
- Morice P, Uzan C, Gouy S, et al. Gynaecological cancers in pregnancy. Lancet. 2012; 379(9815): 558–569.
- Marret H, Lhommé C, Lecuru F, et al. Guidelines for the management of ovarian cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2010; 149(1): 18–21.
- Sayar H, Lhomme C, Verschraegen CF. Malignant adnexal masses in pregnancy. Obstet Gynecol Clin North Am. 2005; 32(4): 569–593.
- Telischak NA, Yeh BM, Joe BN, et al. MRI of adnexal masses in pregnancy. AJR Am J Roentgenol. 2008; 191(2): 364–370.
- Birchard KR, Brown MA, Hyslop WB, et al. MRI of acute abdominal and pelvic pain in pregnant patients. AJR Am J Roentgenol. 2005; 184(2): 452–458.
- Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005; 6(5): 328–333.
- Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997; 70: 130–139.
- Morice P, Uzan C, Gouy S, et al. Gynaecological cancers in pregnancy. Lancet. 2012; 379(9815): 558–569.
- Aslam N, Ong C, Woelfer B, et al. Serum CA125 at 11-14 weeks of gestation in women with morphologically normal ovaries. BJOG. 2000; 107(5): 689–690.
- Sarandakou A, Protonotariou E, Rizos D. Tumor markers in biological fluids associated with pregnancy. Crit Rev Clin Lab Sci. 2007; 44(2): 151–178.
- Muyldermans M, Cornillie FJ, Koninckx PR. Hum Reprod Update. 1995; 1(2): 173–87.
- Han SN, Lotgerink A, Gziri MM, et al. Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review. BMC Med. 2012; 10: 86.
- Drapkin R, von Horsten HH, Lin Y, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res. 2005; 65(6): 2162–2169.
- Moore RG, Miller MC, Eklund EE, et al. Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age. Am J Obstet Gynecol. 2012; 206(4): 349.e1–349.e7.
- Al Musalhi K, Al Kindi M, Al Aisary F, et al. Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass. Oman Med J. 2016; 31(5): 336–344.
- Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol. 2008; 108(2): 402–408.
- Aggarwal P, Kehoe S. Ovarian tumours in pregnancy: a literature review. Eur J Obstet Gynecol Reprod Biol. 2011; 155(2): 119–124.
- Glanc P, Salem S, Farine D. Adnexal masses in the pregnant patient: a diagnostic and management challenge. Ultrasound Q. 2008; 24(4): 225–240.
- Fruscio R, de Haan J, Van Calsteren K, et al. Ovarian cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016 [Epub ahead of print].
- Amant F, Halaska MJ, Fumagalli M, et al. ESGO task force ‘Cancer in Pregnancy’. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer. 2014; 24(3): 394–403.
- Marret H, Lhommé C, Lecuru F, et al. Guidelines for the management of ovarian cancer during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2010; 149(1): 18–21.
- Prat J. FIGO Committee on Gynecologic Oncology. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2014; 124(1): 1–5.
- Rubach M, Mądry R, Wełnicka-Jaśkiewicz M. Nowotwory w ciąży. In: Krzakowski M, Warzocha K. ed. Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych. Via Medica, Gdańsk 2013.
- Amant F, Halaska MJ, Fumagalli M, et al. ESGO task force ‘Cancer in Pregnancy’. Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int J Gynecol Cancer. 2009; 19 Suppl 1(3): S1–12.
- NCCN Guidelines Version 1.2016 Updates Ovarian Cancer.
- Grimm D, Woelber L, Trillsch F, et al. Clinical management of epithelial ovarian cancer during pregnancy. Eur J Cancer. 2014; 50(5): 963–971.
- ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 474: nonobstetric surgery during pregnancy. Obstet Gynecol. 2011; 117(2 Pt 1): 420–421.
- Reginald PW, Beard RW, Chapple J, et al. Outcome of pregnancies progressing beyond 28 weeks gestation in women with a history of recurrent miscarriage. Br J Obstet Gynaecol. 1987; 94(7): 643–648.
- Bates SM, Greer IA, Pabinger I, et al. American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl): 844S–886S.
- Ebert U, Löffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther. 1997; 74(2): 207–220.
- Smith ER, Borowsky ME, Jain VD. Intraperitoneal chemotherapy in a pregnant woman with ovarian cancer. Obstet Gynecol. 2013; 122(2 Pt 2): 481–483.
- Chudecka-Głaz A. Nowotwory germinalne jajnika. In: Markowska J, Mądry J. ed. Zarys ginekologii onkologicznej. Termedia, Poznań 2012.
- Williams S, Blessing JA, Liao SY, et al. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol. 1994; 12(4): 701–706.
- Skrzypczyk-Ostaszewicz A, Rubach M. Gynaecological cancers coexisting with pregnancy - a literature review. Contemp Oncol (Pozn). 2016; 20(3): 193–198.
- Ngu SF, Ngan HYS. Chemotherapy in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016; 33: 86–101.
- Van Calsteren K, Verbesselt R, Ottevanger N, et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand. 2010; 89(10): 1338–1345.
- Lambertini M, Kamal NS, Peccatori FA, et al. Exploring the safety of chemotherapy for treating breast cancer during pregnancy. Expert Opin Drug Saf. 2015; 14(9): 1395–1408.
- Kakoulidis I, Skagias L, Politi E. Pregnancy associated breast cancer (PABC): aspects in diagnosis. Breast Dis. 2015; 35(3): 157–166.
- Jeziorski A, Nowecki ZI. Chirurgiczne leczenie zmian nowotworowych piersi – Konsensus Polskiego Towarzystwa Chirurgii Onkologicznej pod patronatem merytorycznym Konsultanta Krajowego w dziedzinie Chirurgii Onkologicznej. Via Medica , Gdańsk 2016.
- Ray JG, Vermeulen MJ, Bharatha A, et al. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. JAMA. 2016; 316(9): 952–961.
- American College of Obstetricians and Gynecologists' Committee on Obstetric Practice. Committee Opinion No. 656: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol. 2016; 127(2): e75–e80.
- Cardonick E. Pregnancy-associated breast cancer: optimal treatment options. Int J Womens Health. 2014; 6: 935–943.
- Toesca A, Gentilini O, Peccatori F, et al. Locoregional treatment of breast cancer during pregnancy. Gynecol Surg. 2014; 11(4): 279–284.
- Caragacianu DL, Mayer EL, Chun YS, et al. Immediate breast reconstruction following mastectomy in pregnant women with breast cancer. J Surg Oncol. 2016; 114(2): 140–143.
- Lohsiriwat V, Peccatori FA, Martella S, et al. Immediate breast reconstruction with expander in pregnant breast cancer patients. Breast. 2013; 22(5): 657–660.
- Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol. 2015; 1(8): 1145–1153.
- Loibl S, Han SN, Amant F. Being Pregnant and Diagnosed with Breast Cancer. Breast Care (Basel). 2012; 7(3): 204–209.
- Amant F, Loibl S, Neven P, et al. Breast cancer in pregnancy. The Lancet. 2012; 379(9815): 570–579.
- Amant F, Halaska MJ, Fumagalli M, et al. ESGO task force ‘Cancer in Pregnancy’. Breast cancer in pregnancy: recommendations of an international consensus meeting. Eur J Cancer. 2010; 46(18): 3158–3168.
- Loibl S. Adjuvant therapy in patients with breast cancer during pregnancy. Cancer Treat Res. 2009; 151: 317–328.
- Skrzypczyk-Ostaszewicz A, et al. Rak piersi współistniejący z ciążą. Curr Gynecol Oncol. 2014; 12(1).
- Calsteren KV, Verbesselt R, Devlieger R, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer. 2010; 20(9): 1456–1464.
- Lambertini M, Peccatori FA, Azim HA. Targeted agents for cancer treatment during pregnancy. Cancer Treat Rev. 2015; 41(4): 301–309.
- El-Safadi S, Wuesten O, Muenstedt K. Primary diagnosis of metastatic breast cancer in the third trimester of pregnancy: a case report and review of the literature. J Obstet Gynaecol Res. 2012; 38(3): 589–592.
- Peccatori FA, Azim HA, Orecchia R, et al. ESMO Guidelines Working Group. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013; 24 Suppl 6: vi160–vi170.
